One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes Mellitus Marc EvansAngharad R. MorganStephen C. Bain Commentary Open access 26 April 2021 Pages: 1593 - 1604
New Sub-Phenotyping of Subjects at High Risk of Type 2 Diabetes: What Are the Potential Clinical Implications? Djordje S. PopovicManfredi RizzoNikolaos Papanas Commentary Open access 04 May 2021 Pages: 1605 - 1611
Importance of Early Screening and Diagnosis of Chronic Kidney Disease in Patients with Type 2 Diabetes Neil S. SkolnikAlyssa J. Style Review Open access 29 April 2021 Pages: 1613 - 1630
Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review Esther ArtimeIrene RomeraElías Delgado Review Open access 03 May 2021 Pages: 1631 - 1659
A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled Trials Binayak SinhaSamit Ghosal Original Research Open access 24 April 2021 Pages: 1661 - 1676
One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus Stefano RadelliniEnrica VigneriCarla Giordano Original Research Open access 30 April 2021 Pages: 1677 - 1688
Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population with Type 1 or Type 2 Diabetes: The CAN-TREAT Study Stewart B. HarrisOlubukola AjalaDeborah Zwicker Original Research Open access 01 May 2021 Pages: 1689 - 1702
Descriptive Regional Subanalysis of a Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide MR During Fasting: DIA-RAMADAN Mohamed HassaneinSaud Al SifriThamer Alessa Original Research Open access 11 May 2021 Pages: 1703 - 1719
Risk Prediction Model of Gestational Diabetes Mellitus in a Chinese Population Based on a Risk Scoring System Yanmei WangZhijuan GeYan Bi Original Research Open access 15 May 2021 Pages: 1721 - 1734
Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis Tiantian SongYujiao JiaShuchun Chen Original Research Open access 17 May 2021 Pages: 1735 - 1749
Favorable Effects of 24‐Week Whole-Body Vibration on Glycemic Control and Comprehensive Diabetes Therapy in Elderly Patients with Type 2 Diabetes Takumi KitamotoRyuichi SaegusaTakahiko Tokuyama Brief Report Open access 12 May 2021 Pages: 1751 - 1761
Correction to: Injection Technique Education in Patients with Diabetes Injecting Insulin into Areas of Lipohypertrophy: A Randomized Controlled Trial Liming ChenQiuling XingLaurence J. Hirsch Correction Open access 18 May 2021 Pages: 1763 - 1764
Correction to: Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM Ichiro NakamuraHiroshi MaegawaSatoshi Uno Correction Open access 20 May 2021 Pages: 1765 - 1768